Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. Burm R, Maravelia P, Ahlen G, Ciesek S, et al. Gut 2022 Aug 17. pii: gutjnl-2022-327216. doi: 10.1136/gutjnl-2022-327216.

Read + Share

Amedeo Smart

Independent Medical Education

Burm R, Maravelia P, Ahlen G, Ciesek S, et al. Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. Gut 2022 Aug 17. pii: gutjnl-2022-327216. doi: 10.1136/gutjnl-2022-327216.
PMID: 35977815